We are live on
!
Find out more
O
OppenheimerFunds Portfolio holdings
AUM
$80.4B
1-Year Est. Return
15.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.22%
1 Year Est. Return
+15.1%
3 Year Est. Return
+72.05%
5 Year Est. Return
+91.1%
10 Year Est. Return
–
AUM
$79.7B
AUM Growth
+$3.42B
(+4.5%)
Cap. Flow
-$854M
Cap. Flow
% of AUM
-1.07%
Top 10 Holdings %
Top 10 Hldgs %
14.29%
Holding
1,817
New
122
Increased
851
Reduced
711
Closed
96
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson Controls International
JCI
|
+$281M |
| 2 |
Comcast
CMCSA
|
+$235M |
| 3 |
Apple
AAPL
|
+$172M |
| 4 |
MetLife
MET
|
+$151M |
| 5 |
Mid-America Apartment Communities
MAA
|
+$148M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$399M |
| 2 |
UBS Group
UBS
|
+$393M |
| 3 |
Televisa
TV
|
+$305M |
| 4 |
TYC
TYCO INTL PLC COM SHS (IRL)
TYC
|
+$278M |
| 5 |
New Oriental
EDU
|
+$169M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Energy | 15.42% |
| 2 | Financials | 13.04% |
| 3 | Healthcare | 11.98% |
| 4 | Consumer Discretionary | 11.9% |
| 5 | Technology | 10.26% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ARIA
501
DELISTED
Ariad Pharmaceuticals Inc
ARIA
| $25.6M | 0.03% |
1,870,920
+10,060
| +0.5% | +$101K |
|
502
Associated Banc-Corp
ASB
$5.81B
| $25.6M | 0.03% |
1,304,742
+3,567
| +0.3% | +$67.4K |
|
503
Inogen
INGN
$167M
| $25.5M | 0.03% |
426,412
+27,767
| +7% | +$1.55M |
|
|
MON
504
DELISTED
Monsanto Co
MON
| $25.5M | 0.03% |
249,105
-6,815
| -3% | -$715K |
|
505
Brinker International
EAT
$8.02B
| $25.5M | 0.03% |
504,735
-327
| -0.1% | -$16.4K |
|
|
OCLR
506
DELISTED
Oclaro Inc.
OCLR
| $25.3M | 0.03% |
+2,963,308
| New | +$20.6M |
|
507
Tapestry
TPR
$28.8B
| $25.3M | 0.03% |
692,677
-1,308,893
| -65% | -$51.9M |
|
508
Pinnacle Financial Partners Inc
PNFP
$15.5B
| $25.3M | 0.03% |
468,211
+30,508
| +7% | +$1.65M |
|
509
Raymond James Financial
RJF
$32.5B
| $25.3M | 0.03% |
651,983
+294,224
| +82% | +$10.8M |
|
510
Alarm.com
ALRM
$2.56B
| $25.3M | 0.03% |
+875,160
| New | +$24.4M |
|
511
Hormel Foods
HRL
$13.9B
| $25M | 0.03% |
659,637
+45,877
| +7% | +$1.7M |
|
512
Fortive
FTV
$19B
| $24.9M | 0.03% |
+776,210
| New | +$24.9M |
|
513
Valero Energy
VLO
$89.8B
| $24.6M | 0.03% |
463,510
+64,476
| +16% | +$3.44M |
|
514
Tanger
SKT
$4.82B
| $24.5M | 0.03% |
627,972
-116,939
| -16% | -$4.73M |
|
515
International Paper
IP
$22.3B
| $24.3M | 0.03% |
535,524
-72,961
| -12% | -$3.22M |
|
516
Monster Beverage
MNST
$91.4B
| $24.2M | 0.03% |
987,348
+75,240
| +8% | +$1.95M |
|
517
Bankunited
BKU
$3.38B
| $24M | 0.03% |
794,768
-300,822
| -27% | -$9.22M |
|
|
ENH
518
DELISTED
Endurance Specialty Holdings Ltd
ENH
| $23.8M | 0.03% |
363,965
+11,683
| +3% | +$775K |
|
519
Ultragenyx Pharmaceutical
RARE
$2.65B
| $23.6M | 0.03% |
333,191
-58,122
| -15% | -$3.71M |
|
|
WPX
520
DELISTED
WPX Energy, Inc.
WPX
| $23.6M | 0.03% |
1,788,238
-322,461
| -15% | -$3.58M |
|
|
STOR
521
DELISTED
STORE Capital Corporation
STOR
| $23.5M | 0.03% |
+797,100
| New | +$23.7M |
|
522
Intuitive Surgical
ISRG
$121B
| $23.4M | 0.03% |
290,286
+26,487
| +10% | +$2.03M |
|
|
SEE
523
DELISTED
Sealed Air
SEE
| $23.3M | 0.03% |
509,235
+36,413
| +8% | +$1.71M |
|
|
TWX
524
DELISTED
Time Warner Inc
TWX
| $23.3M | 0.03% |
292,988
+256,983
| +714% | +$20.1M |
|
525
SL Green Realty
SLG
$3.88B
| $23.3M | 0.03% |
222,652
-56,926
| -20% | -$6.25M |
|
Similar funds
TA
TCIM
HFS
SBAM
BB
SA
WF
BCPEM
OppenheimerFunds's Q3 2016 Portfolio in Review
As of Q3 2016, OppenheimerFunds held 1,817 positions worth $79.7B, up 4.5% from $76.2B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
OppenheimerFunds's Q3 2016 filing shows 122 new, 851 increased, 711 reduced and 96 closed positions. Its largest new stake was Fomento Económico Mexicano: 1,462,419 shares worth $135M. The largest sale was Bristol-Myers Squibb, an estimated $399M.
By sector, the portfolio is most concentrated in Energy at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.
- OppenheimerFunds's largest Q3 2016 buy was Fomento Económico Mexicano: 1,462,419 shares worth $135M.
- OppenheimerFunds added most to Johnson Controls International in Q3 2016, an estimated $281M increase.
- OppenheimerFunds's biggest Q3 2016 reduction was Bristol-Myers Squibb, cutting an estimated $399M.
- OppenheimerFunds fully exited UBS Group in Q3 2016, selling an estimated $393M.
- OppenheimerFunds's ten largest holdings make up 14% of its $79.7B portfolio in Q3 2016.
- OppenheimerFunds opened 122 new positions and closed 96 in Q3 2016.
- OppenheimerFunds's portfolio value rose 4.5% quarter-over-quarter to $79.7B.
Based on OppenheimerFunds's 13F filing for Q3 2016, filed 14 Nov 2016.